ArticleMedChemComm2016
Potentiation of
Article in MedChemComm, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Genetic Determinants of Antibiotic Resistance inFrontiers in microbiology · 2021Review
- Article
- Second-Generation Tryptamine Derivatives Potently Sensitize Colistin Resistant Bacteria to Colistin.ACS medicinal chemistry letters · 2019Article
- Two-Component Systems inFrontiers in cellular and infection microbiology · 2019Review
- New Class of Adjuvants Enables Lower Dosing of Colistin Against Acinetobacter baumannii.ACS infectious diseases · 2018Article
- Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery.Molecules (Basel, Switzerland) · 2018Article
- Article
- Francisella philomiragia Infection and Lethality in Mammalian Tissue Culture Cell Models, Galleria mellonella, and BALB/c Mice.Frontiers in microbiology · 2016Article
- Potentiation of the Fosmidomycin analogue FR 900098 with substituted 2-oxazolines againstMedChemComm · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
A screen of 20 compounds identified small molecule adjuvants capable of potentiating anitbiotic activty against
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.